ENVERSE Trademark

Trademark Overview


On Thursday, July 29, 2021, a trademark application was filed for ENVERSE with the United States Patent and Trademark Office. The USPTO has given the ENVERSE trademark a serial number of 90855807. The federal status of this trademark filing is REGISTERED as of Tuesday, October 11, 2022. This trademark is owned by Stimlabs LLC. The ENVERSE trademark is filed in the Pharmaceutical Products category with the following description:

Human allograft tissue
enverse

General Information


Serial Number90855807
Word MarkENVERSE
Filing DateThursday, July 29, 2021
Status700 - REGISTERED
Status DateTuesday, October 11, 2022
Registration Number6874177
Registration DateTuesday, October 11, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 24, 2022

Trademark Statements


Goods and ServicesHuman allograft tissue
Pseudo MarkINVERSE

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 27, 2021
Primary Code005
First Use Anywhere DateFriday, July 1, 2022
First Use In Commerce DateFriday, July 1, 2022

Trademark Owner History


Party NameStimlabs LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressRoswell, GA 30076

Party NameStimlabs LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressRoswell, GA 30076

Party NameStimlabs LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressRoswell, GA 30076

Trademark Events


Event DateEvent Description
Tuesday, October 11, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 11, 2022REGISTERED-PRINCIPAL REGISTER
Wednesday, September 7, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 6, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, August 26, 2022STATEMENT OF USE PROCESSING COMPLETE
Friday, August 12, 2022USE AMENDMENT FILED
Friday, August 26, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 12, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, July 19, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 24, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 24, 2022PUBLISHED FOR OPPOSITION
Wednesday, May 4, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 19, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 18, 2022ASSIGNED TO EXAMINER
Monday, September 27, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, August 2, 2021NEW APPLICATION ENTERED IN TRAM

Related Keywords


enverse tissue allograft human